Section Arrow
VOR.NASDAQ
- Vor Biopharma Inc
Quotes are at least 15-min delayed:2026/02/22 04:12 EST
Regular Hours
Last
 13.55
+0.24 (+1.80%)
Day High 
13.78 
Prev. Close
13.31 
1-M High
18.6 
Volume 
424.03K 
Bid
13.25
Ask
13.85
Day Low
13.0002 
Open
13.27 
1-M Low
11.46 
Market Cap 
552.63M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 13.1 
20-SMA 13.67 
50-SMA 13.47 
52-W High 65.8 
52-W Low 2.622 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-386.86/-7.01
Enterprise Value
580.24M
Balance Sheet
Book Value Per Share
-53.60
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CDIOCardio Diagnostics Holdings Inc.2.88+0.64+28.57%-- 
IBRXImmunityBio8.7+0.09+1.05%-- 
GERNGeron Corp1.88-0.04-2.08%-- 
QNCXQuince Therapeutics0.1501-0.0121-7.46%-- 
RXRXRecursion Pharmaceuticals3.42-0.3-8.06%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.